The chronic myelogenous leukemia-specific p210 protein is the product of the bcr-abl hybrid gene, Science, vol.132, p.212, 1960. ,
Unregulated proliferation of primitive chronic myelogenous leukemia progenitors in the presence of normal marrow adherent cells, Proc Natl Acad Sci, vol.247, p.824, 1986. ,
Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia, Cancer Res, vol.36, 1976. ,
Biological consequences of p160v-abl protein tyrosine kinase activity in a primitive, multipotent hematopoietic cell line, Leukemia, vol.8, p.620, 1994. ,
The suppression of druginduced apoptosis by activation of v-abl protein tyrosine kinase, Cancer Res, vol.54, 1994. ,
Inhibition of apoptosis by BCR-ABL in chronic myelogenous leukemia, Blood, vol.83, p.2038, 1994. ,
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents, Blood, vol.86, p.1179, 1994. ,
Bcr/abl expression in 32D c13(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors, Cancer Res, vol.54, p.1360, 1994. ,
Regulation of the Fas apoptotic cell death pathway by Abl, J Biol Chem, vol.270, p.22625, 1995. ,
Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haematopoietic cell line, J Cell Sci, vol.8, p.2591, 1995. ,
Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line, J Exp Med, vol.180, 1994. ,
AD: V-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation, J Biol Chem, vol.13, p.2589, 1995. ,
Human ICE/CED-3 protease nomenclature, Cell, vol.87, p.171, 1996. ,
The role of proteases during apoptosis, FASEB J, vol.10, 1996. ,
The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors, mice deficient in interleukin-1?-converting enzyme, vol.267, p.1113, 1995. ,
Differential induction of apoptosis in undifferentiated and differentiated HL60 cells by DNA topoisomerase I and II inhibitors, Nucleic Acids Res, vol.81, p.1215, 1985. ,
Bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidilate stress is independent of classical resistance pathways, J Cell Biochem, vol.271, p.33, 1992. ,
Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor ?1 and cancer chemotherapy compounds in myeloid leukemic cells, Nature, vol.80, p.1750, 1992. ,
Cleavage of Poly(ADP-ribose)polymerase by interleukin-1? converting enzyme and its homologs Tx and Nedd-2, J Biol Chem, vol.32, p.446, 1995. ,
Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligonucleotides combined with mafosfamide, J Clin Invest, vol.92, 1993. ,